{"name":"KRKA","slug":"krka","ticker":"KRKG","exchange":"Ljubljana Stock Exchange (LJ)","domain":"krka.biz","description":"KRKA is a Slovenian pharmaceutical company that specializes in the development and manufacturing of generic and specialty pharmaceuticals. The company focuses on therapeutic areas such as cardiovascular, central nervous system, and gastrointestinal disorders. KRKA's key products include Co-Amlessa and Amlessa, which are marketed in various regions. As a leading generics and specialty pharma company, KRKA operates in a competitive market with a strong presence in Europe and other regions.","hq":"Novo Mesto, Slovenia","founded":1960,"employees":"~3,500","ceo":"Jože Colarič","sector":"Generics / Specialty Pharma","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"2.3B","metrics":{"revenue":1900000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Co-Amlessa patent cliff ($1.2B at risk)","drug":"Co-Amlessa","type":"patent_expiry","sentiment":"negative"},{"date":"2029-06-01","label":"Amlessa patent cliff ($800M at risk)","drug":"Amlessa","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Co-Amlessa®","genericName":"Co-Amlessa®","slug":"co-amlessa","indication":"Other","status":"marketed"},{"name":"Amlessa®","genericName":"Amlessa®","slug":"amlessa","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Co-Amlessa®","genericName":"Co-Amlessa®","slug":"co-amlessa","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Amlessa®","genericName":"Amlessa®","slug":"amlessa","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"KRKA Reports Strong Q4 2023 Earnings","summary":"KRKA reported strong Q4 2023 earnings, driven by increased sales of its generic and specialty pharmaceuticals.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"KRKA Partners with CDMO to Enhance Manufacturing Capacity","summary":"KRKA partnered with a contract development and manufacturing organization (CDMO) to enhance its manufacturing capacity and improve efficiency.","drugName":"","sentiment":"neutral"},{"date":"2023-06-15","type":"regulatory","headline":"KRKA Receives FDA Approval for Generic Version of Amlessa","summary":"KRKA received FDA approval for its generic version of Amlessa, expanding its product portfolio in the US market.","drugName":"Amlessa","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPVTJkbF9DeUVvT29XSU1COEE4N3h2Q25lbXc0eVNlQUt0dEt1SXJ1ODR0Q0xSNHBaQTJhOGE5V0JYZjg0clJpSFpZWlRiWWJTUUh4NjN5TEhWOU5uQW9WUm1rRF9DdkZHaWlrTkR0TmYxVkQ5enJmTXVwc2ZnSTVFbW00RW9XaWlVckZSNlRjY3ZlcEx3MTlvSA?oc=5","date":"2026-03-28","type":"pipeline","source":"TradingView","summary":"Operating expenses (excl. COGS) of Krka, d. d., Novo mesto – LJSE:KRKG - TradingView","headline":"Operating expenses (excl. COGS) of Krka, d. d., Novo mesto – LJSE:KRKG","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-11","type":"pipeline","source":"simplywall.st","summary":"Some Confidence Is Lacking In Krka, d. d.'s (LJSE:KRKG) P/E - simplywall.st","headline":"Some Confidence Is Lacking In Krka, d. d.'s (LJSE:KRKG) P/E","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-06","type":"earnings","source":"simplywall.st","summary":"Do Krka d. d's (LJSE:KRKG) Earnings Warrant Your Attention? - simplywall.st","headline":"Do Krka d. d's (LJSE:KRKG) Earnings Warrant Your Attention?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBhSnJrWWpSc1ZmcndySXl5alZKOURkWkdKUmNFWDU3TmVpb29ObEQtNW0temszZ3RyQ1ZuSzhGemxuLU5DWE1IYzZFVmltMzVwYjlWZU93X3I3dw?oc=5","date":"2025-10-10","type":"pipeline","source":"TradingView","summary":"KRKG Stock Price and Chart — LJSE:KRKG - TradingView","headline":"KRKG Stock Price and Chart — LJSE:KRKG","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-03","type":"pipeline","source":"simplywall.st","summary":"We Think Krka, d. d.'s (LJSE:KRKG) CEO Compensation Looks Fair - simplywall.st","headline":"We Think Krka, d. d.'s (LJSE:KRKG) CEO Compensation Looks Fair","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNWG96Q2Y2Y3dROVJnS0thc1h3WTVzMzY1M3RpeS0xY2RvbGU1UWxEaFY3N2JsSFVqU1ZnVjF6eHlFNnFwS0ZSVWFYR1Bna01PWnd2ZEhvb3E2bFNQUUtyaWlkaU9kVl9qd24yZ2RsbEtnajQ5SjhLQnFVS1hYQVVZc1ljU2xCZzBZRDRTVQ?oc=5","date":"2025-05-15","type":"earnings","source":"SeeNews","summary":"Slovenia's Krka net profit rises 54% y/y in Q1 - SeeNews","headline":"Slovenia's Krka net profit rises 54% y/y in Q1","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxORlBUOWtXMWcwX1BqdFdxeFM4emNFeWNoaHptZUFiREZXVV81TndFMG0xTy1FUmFSczZ3NVFLZHZXcFZrbDZoUzJ0T09BbkhDZWk4MGtLVk5VenhaaUpjaExHcnppeS1OcjlWY1UzaFZPSjg3enRIemFDOTZhZ2F0ZDV1cTZFaG8?oc=5","date":"2024-07-02","type":"pipeline","source":"SeeNews","summary":"CJEU upholds 10 mln euro fine on Slovenia's Krka - SeeNews","headline":"CJEU upholds 10 mln euro fine on Slovenia's Krka","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE8xMnFmME5NX2JscU9uYWJoUk94LTl2RlUtYlViWU5ETmdhWWxpNmpUNHdWak1ONi1DT0FDOFU2YU9EcXN6QmVyQ3hZSGJpRENfRlM4cEtZUWVOb1ZwaGRuc1hCT1E3TEdqWlJ6aWU0THJFQjlQekRIbnF2ZVQ?oc=5","date":"2023-07-27","type":"pipeline","source":"SeeNews","summary":"Krka helps Ljubljana share indices rise - SeeNews","headline":"Krka helps Ljubljana share indices rise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQUWhsUjA0bnZOQnBWTl90eWRlaGhNUkZlbk13V05SU28xdEFuWS1zN1NEbkdKRS1MM0w4eXF6STdIVC1udGJrLVdBUVE4YUVsSWh2czkyYmJZbGpMZ3pVNUhPSk5HaGFJWWR4cDdqRThuMUxGS3FGeU9fM1M1dmMwRjk0eThkTE1vbEdCWDl2cDF1NVJYNEdMNmFmaUFndw?oc=5","date":"2023-01-31","type":"pipeline","source":"SeeNews","summary":"Slovenia's Krka to invest 163 mln euro in Krsko factory expansion - SeeNews","headline":"Slovenia's Krka to invest 163 mln euro in Krsko factory expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9JNXpIVk5iTngxTnBmVDBTMGZaZVRNbFBIcm0tZGlGUmJwbzRabTRCbnZxVzBXVzA2OFFQX2ZRSnBxZlVlNmthTFd3RWpQQ0lSNUpRb0VVMGoteHpMcDBhSkkyT0JCN0xTX3liRW5xNW9oZDZMVEx1c0tR?oc=5","date":"2020-08-21","type":"pipeline","source":"marketscreener.com","summary":"Krka, d. d.: Target Price Consensus and Analysts Recommendations | KRKG | SI0031102120 - marketscreener.com","headline":"Krka, d. d.: Target Price Consensus and Analysts Recommendations | KRKG | SI0031102120","sentiment":"neutral"}],"patents":[{"drugName":"Co-Amlessa","drugSlug":"amlodipine-and-olmesartan","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1200000000},{"drugName":"Amlessa","drugSlug":"amlodipine-and-olmesartan","patentNumber":"","type":"Patent Cliff","expiryDate":"2029-06-01","territory":"EU","annualRevenue":800000000}],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sandoz","Teva Pharmaceuticals","Mylan"],"therapeuticFocus":["Cardiovascular","Central Nervous System","Gastrointestinal"],"financials":null,"yahoo":null}